Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Corrigendum]

• Hlavní autoři: Abe M (Autor), Tsushima K (Autor), Sakayori M (Autor), Suzuki K (Autor), Ikari J (Autor), Terada J (Autor), Tatsumi K (Autor)
• Médium: Kniha
• Vydáno: Dove Medical Press, 2019-02-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Abe M, Tsushima K, Sakayori M, et al. Drug Des Devel Ther. 2018;12:3369–3375.On page 3372, last paragraph of “Results” section should read from “In Severe Group, patients who were able to continue nintedanib for more than 3 months (n...